» Articles » PMID: 17261681

Frequency of and Risk Factors for HIV Dementia in an HIV Clinic in Sub-Saharan Africa

Overview
Journal Neurology
Specialty Neurology
Date 2007 Jan 31
PMID 17261681
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To measure the frequency and associated risk factors of HIV dementia in an HIV clinic in Kampala, Uganda.

Methods: We systematically sampled 78 HIV-seropositive (HIV+) patients from an ambulatory HIV clinic. Participants underwent detailed sociodemographic, medical history, functional, neurologic, and neuropsychological evaluations. One hundred HIV-negative patients were recruited to provide normative data for the neuropsychological tests. A logistic regression model was constructed to determine risk factors associated with the diagnosis of HIV dementia.

Results: Thirty-one percent (24 of 78) of the HIV+ patients had HIV dementia. Advanced age and low CD4(+) T-lymphocyte count (CD4 count) were the only variables identified as significant risk factors in the logistic regression model. Each additional 10 years of age conferred a greater than twofold risk of HIV dementia (OR 2.06, 95% CI: 1.05 to 4.07; p < 0.05). Reduced levels of CD4 count (100 cells/muL decrement) was associated with a 60% increase in the odds of having HIV dementia (OR 1.6, 95% CI: 1.04 to 2.33; p < 0.05).

Conclusion: HIV dementia is common in HIV-seropositive Ugandan individuals attending an AIDS clinic. It is more frequently associated with patients of advanced age and decreased CD4 count.

Citing Articles

Neurocognitive Impairment Among Cryptococcal Meningitis Survivors in Uganda, a Prospective Cohort Study.

Nsangi L, Hullsiek K, Dai B, Namudde A, Menya G, Ssebambulidde K Open Forum Infect Dis. 2025; 12(2):ofaf054.

PMID: 40008306 PMC: 11850114. DOI: 10.1093/ofid/ofaf054.


Factors associated with verbal fluency in older adults living with HIV in West Africa: A longitudinal study.

Bernard C, Font H, Diallo Z, Ahonon R, Tine J, Abouo F Trop Med Int Health. 2022; 28(1):35-42.

PMID: 36398852 PMC: 9812871. DOI: 10.1111/tmi.13830.


Neurocognitive outcomes of tuberculous meningitis in a primarily HIV-positive Ugandan cohort.

Quinn C, Kasibante J, Namudde A, Bangdiwala A, Kabahubya M, Nakasujja N Wellcome Open Res. 2022; 6:208.

PMID: 35949653 PMC: 9334841. DOI: 10.12688/wellcomeopenres.16967.2.


A Meta-Analytic Review of the Effect of Antiretroviral Therapy on Neurocognitive Outcomes in Adults Living with HIV-1 in Low-and Middle-Income Countries.

Michael H, Youbi E, Ohadoma S, Ramlall S, Oosthuizen F, Polyakova M Neuropsychol Rev. 2021; 32(4):828-854.

PMID: 34757490 DOI: 10.1007/s11065-021-09527-y.


HIV Associated Neurocognitive Disorders Subsidence Through Citalopram Addition in Anti-retroviral Therapy (HANDS-CARE): A Concept Note.

Ojagbemi A Front Neurol. 2021; 12:658705.

PMID: 34381409 PMC: 8350562. DOI: 10.3389/fneur.2021.658705.